Skip to main content
The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Jul 28, 2026
Thermo Fisher’s single-use strategy | Kyverna, ElevateBio sign manufacturing agreement
Jul 25, 2026
Trump’s generic drug tariffs threaten US supply | New ophthalmic production site in France
Jul 24, 2026
Siegfried overtakes Lonza in HPAPI race | BeOne invests $300M in NJ expansion
Jul 23, 2026
Commerce Department funds Tech Hubs | Repligen boosts cell therapy business with $1.5B buy
Jul 22, 2026
AstraZeneca’s award-winning cell therapy site | Cellares, Papillon team to automate manufacturing
Jul 21, 2026
Samsung Biologics buys PolyPeptide for $1.8B | BMS, NVIDIA team on ‘AI factory’
Jul 18, 2026
Senate bill targets foreign drugmaking in US | MilliporeSigma opens German testing facility
Jul 17, 2026
J&J streamlines its pharma supply chain | Cytovance adds perfusion capabilities
Jul 16, 2026
Bora Pharmaceuticals, Insilico Medicine form AI drug alliance | Formycon, OneSource team on biosimilars
Jul 15, 2026
Biopharma demand poised to improve | Charles River provides GMP NGS services to Arovella
Jul 14, 2026
FDA to modernize drug manufacturing registration | Cellares, Sonoma team on Treg manufacturing
Jul 11, 2026
Dr. Reddy’s halts generic semaglutide production | WuXi Biologics gets FDA PLI approval
Jul 10, 2026
Cellares touts unique position in FDA pilot | Evonik invests $100M in Indiana site
Jul 9, 2026
Resilience looks to find its footing in CDMO space | Autolomous, Cellular Origins team on platforms
Jul 8, 2026
Single-use technology reshapes biopharma | Codis buys Catalent’s UK facility
Jul 7, 2026
Europe-US new drug manufacturing outsourcing gap grows | Bora completes MacroGenics buy
Jul 3, 2026
Oligonucleotide CDMO market set to jump | WuXi Biologics sites get Brazil GMP certification
Jul 2, 2026
Endress+Hauser opens new PA campus | AGC Biologics boosts US fill-finish via partnership
Jul 1, 2026
7 companies picked for FDA PreCheck pilot | Lonza adds payload-linker manufacturing capacity
Jun 30, 2026
AI & vaccine manufacturing | 1st radiopharma manufacturing license under China’s new rules
Jun 27, 2026
WuXi Biologics dodges bullet | Mammoth to advance gene-editing therapies in Abu Dhabi
Jun 26, 2026
Chemical engineering & process development | GMP production at WuXi Biologics’ MFG17
Jun 25, 2026
Lonza racks up ADC deals | Shilpa commissions ADC manufacturing facility in India
Jun 24, 2026
China leads US in biomanufacturing | AdvanCell’s strategy to expand US footprint
Jun 23, 2026
Lotte Biologics completes plant construction | Cellares vs. Ori Biotech in automation battle
Latest Edition